SCHEMBL980248

SCHEMBL980248

O=C(O)c1cc2cccc(Br)c2oc1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.71
GPR35 Q9HC97 14/20 0.65
ALDH1A1 P00352 1/20 0.63
LMNA P02545 1/20 0.63
HPGD P15428 1/20 0.63
CA12 O43570 2/20 0.62
CA1 P00915 2/20 0.62
CA3 P07451 2/20 0.62
CA4 P22748 2/20 0.62
CA6 P23280 2/20 0.62
CA5A P35218 2/20 0.62
CA7 P43166 2/20 0.62
CA9 Q16790 2/20 0.62
CA14 Q9ULX7 2/20 0.62
CA5B Q9Y2D0 2/20 0.62
CA2 P00918 1/20 0.62
MAOB P27338 3/20 0.57
TSHR P16473 1/20 0.57
GRIN1 Q05586 1/20 0.53
GRIN2A Q12879 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31315657 1.00 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL977935 0.83 MAOA (1.00) MAOAGPR35ALDH1A1LMNAHPGD
Hydrochloric Acid SCHEMBL11344142 0.82 MAOA (0.97) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL18306420 0.81 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL31315659 0.81 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL11341006 0.81 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL980080 0.81 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL31315660 0.81 MAOA (0.71) MAOAGPR35ALDH1A1LMNAHPGD
SCHEMBL3080344 0.79 GPR35 (1.00) MAOAGPR35ALDH1A1HPGDMAOB
SCHEMBL16976893 0.79 MAOB (0.76) MAOAALDH1A1HPGDCA12CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435068-B2 Anthelmintic compounds ELANCO ANIMAL HEALTH GMBH (DE) 2025-10-07 US disclosed
CN-119409690-A Novel insect repellent compound 拜耳动物保健有限责任公司 2025-02-11 CN disclosed
CN-112939916-B Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2022-08-19 CN disclosed
US-20210380566-A1 NEW ANTHELMINTIC COMPOUNDS ELANCO ANIMAL HEALTH GMBH (DE) 2021-12-09 US disclosed
US-20210380566-A1 NEW ANTHELMINTIC COMPOUNDS ELANCO ANIMAL HEALTH GMBH (DE) 2021-12-09 US disclosed
CN-113166123-A Novel insect repellent compounds 拜耳动物保健有限责任公司 2021-07-23 CN disclosed
CN-113024499-A Green synthesis method of coumarin-3-carboxylic acid compounds 河南中烟工业有限责任公司 2021-06-25 CN disclosed
CN-112939916-A Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2021-06-11 CN disclosed
EP-3643711-A1 NEW ANTHELMINTIC COMPOUNDS Bayer Animal Health GmbH (DE) 2020-04-29 EP disclosed
EP-3643711-A1 NEW ANTHELMINTIC COMPOUNDS Bayer Animal Health GmbH (DE) 2020-04-29 EP disclosed
US-9518038-B2 Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) 2016-12-13 US disclosed
US-8642788-B2 Activators of executioner procaspases 3, 6 and 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-02-04 US disclosed
CN-101965189-A Activators of pro-caspase 3, 6 and 7 UNIV CALIFORNIA 2011-02-02 CN disclosed
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed
EP-2237784-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 The Regents of the University of California (US) 2010-10-13 EP disclosed
WO-2009089508-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 CASP7, CASP3, CASP6 MAOA 2101/4885GPR35 4234/4885ALDH1A1 2806/4885
US-12435068-B2 Anthelmintic compounds H1-10, HRH2, HRH1 MAOA 694/4885GPR35 758/4885ALDH1A1 457/4885
US-20210380566-A1 NEW ANTHELMINTIC COMPOUNDS H1-10, HRH2, HRH4 MAOA 961/4885GPR35 743/4885ALDH1A1 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.